Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Biological Sciences: Human Brain Monoamine Oxidase: Multiple Forms and Selective Inhibitors

Abstract

IT is well recognized that monoamine oxidase (monoamine: O2 oxidoreductase (deaminating), EC 1.4.3.4) (MAO) plays an important role in the degradation of biologically active monoamines in the brain1,2. There is much evidence pointing to changes in monoamine metabolism in mental illnesses characterized by alterations in mood3,4. Perhaps the most important property of MAO inhibiting drugs is their ability to bring about a lightening of affect in depressed patients5. That this effect results solely from the inhibition of MAO has not been widely questioned, although the antidepressive effect is not shared to an equal extent by all drugs in the group6. An attempt has been made to explain this finding in terms of differing ability of the MAO inhibitors to prevent amine re-uptake7; however, it has seemed to us that an explanation might better be sought in terms of differential inhibitory capacity of these drugs on the four molecular variants of MAO in the human brain8.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kopin, I. J., Pharmacol. Rev., 18, 513 (1966).

    CAS  PubMed  Google Scholar 

  2. Roffler-Tarlov, S., Sharman, D. F., and Tegerdine, D., Brit. J. Pharmacol., 42, 343 (1971).

    Article  CAS  Google Scholar 

  3. Schildkraut, J. J., in Biochemistry, Schizophrenia and Affective Illnesses (edit. by Himwich, H. E.), 198 (Williams and Wilkins, Baltimore, 1970).

    Google Scholar 

  4. Himwich, H. E., in Biochemistry, Schizophrenia and Affective Illnesses (edit. by Himwich, H. E.), 230 (Williams and Wilkins, Baltimore, 1970).

    Google Scholar 

  5. Hordern, A., New Engl. J. Med., 272, 1159 (1965).

    Article  CAS  Google Scholar 

  6. Davis, J. M., Arch. Gen. Psychiat., 13, 552 (1965).

    Article  CAS  Google Scholar 

  7. Hendley, E. D., and Snyder, S. H., Nature, 220, 1330 (1968).

    Article  ADS  CAS  Google Scholar 

  8. Youdim, M. B. H., Collins, G. G. S., and Sandler, M., Nature, 223, 626 (1969).

    Article  ADS  CAS  Google Scholar 

  9. Collins, G. G. S., Sandler, M., Williams, E. D., and Youdim, M. B. H., Nature, 225, 817 (1970).

    Article  ADS  CAS  Google Scholar 

  10. Sandler, M., Collins, G. G. S., and Youdim, M. B. H., in Mechanisms of Toxicity (edit. by Aldridge, W. N.), 4 (Macmillan, London, 1971).

    Google Scholar 

  11. Hawkins, J., Biochem. J., 50, 577 (1952).

    Article  CAS  Google Scholar 

  12. Kraml, M., Biochem. Pharmacol., 14, 1684 (1965).

    Article  Google Scholar 

  13. Robinson, D. S., Lovenberg, W., Keiser, H., and Sjoerdsma, A., Biochem. Pharmacol., 17, 109 (1968).

    Article  CAS  Google Scholar 

  14. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. Biol. Chem., 193, 265 (1951).

    CAS  Google Scholar 

  15. Youdim, M. B. H., and Sourkes, T. L., Canad. J. Biochem., 44, 1397 (1966).

    Article  CAS  Google Scholar 

  16. Youdim, M. B. H., Collins, G. G. S., and Sandler, M., in Enzymes and Isoenzymes. Structure, Properties and Function, Fifth FEBS Meeting (edit. by Shugar, D.), 18, 281 (Academic Press, London, 1970).

    Google Scholar 

  17. Pletscher, A., Gey, K. F., and Burkard, W. P., in Handbook of Experimental Pharmacology, 5-Hydroxytryptamine and Related Indolalkylamines (edit. by Erspamer, V.), 19, 593 (Springer, Berlin, 1966).

    Book  Google Scholar 

  18. Johnson, J. P., Biochem. Pharmacol., 17, 1285 (1968).

    Article  Google Scholar 

  19. Lader, M. H., Sakalis, G., and Tansella, M., Psychopharmacologia, 18, 118 (1970).

    Article  CAS  Google Scholar 

  20. Asatoor, A. M., Levi, A. J., and Milne, M. D., Lancet, ii, 733 (1963).

  21. Blackwell, B., Lancet, ii, 414 (1963).

  22. Blackwell, B., Lancet, ii, 849 (1963).

  23. Youdim, M. B. H., in Monoamine Oxidases. New Vistas (edit. by Costa, E., and Sandler, M.) (Raven Press, New York, in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

YOUDIM, M., COLLINS, G., SANDLER, M. et al. Biological Sciences: Human Brain Monoamine Oxidase: Multiple Forms and Selective Inhibitors. Nature 236, 225–228 (1972). https://doi.org/10.1038/236225b0

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1038/236225b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing